SCHEMBL29016992

SCHEMBL29016992

CNC(C)CCc1ccc2ccoc2c1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 10/20 0.73
CHRM2 P08172 2/20 0.51
CHRM1 P11229 2/20 0.51
CHRM3 P20309 2/20 0.51
LMNA P02545 2/20 0.37
KDM4E B2RXH2 2/20 0.37
MAPK1 P28482 2/20 0.37
SLC6A4 P31645 2/20 0.37
HTT P42858 2/20 0.37
SLC22A1 O15245 1/20 0.37
CA12 O43570 1/20 0.37
EGFR P00533 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
CA3 P07451 1/20 0.37
ADRB2 P07550 1/20 0.37
ADRB1 P08588 1/20 0.37
ADRA2A P08913 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25278519 1.00 HTR1B (0.73) HTR1BCHRM2CHRM1CHRM3LMNA
Hydrochloric Acid SCHEMBL25238177 0.98 HTR1B (0.71) HTR1BCHRM2CHRM1CHRM3LMNA
Hydrochloric Acid SCHEMBL25236578 0.98 HTR1B (0.71) HTR1BCHRM2CHRM1CHRM3LMNA
SCHEMBL25281414 0.88 HTR1B (0.73) HTR1BCHRM2CHRM1CHRM3TSHR
SCHEMBL29016973 0.88 HTR1B (0.73) HTR1BCHRM2CHRM1CHRM3TSHR
SCHEMBL25276454 0.88 HTR1B (0.73) HTR1BCHRM2CHRM1CHRM3TSHR
Hydrochloric Acid SCHEMBL25278919 0.87 HTR1B (0.71) HTR1BCHRM2CHRM1CHRM3LMNA
SCHEMBL24111276 0.84 HTR1B (1.00) HTR1BSLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL24111395 0.84 HTR1B (1.00) HTR1BSLC6A4SLC6A2SLC6A3CYP2D6
SCHEMBL24111392 0.84 HTR1B (1.00) HTR1BSLC6A4SLC6A2SLC6A3CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116075300-A Advantageous benzofuran compositions for mental disorders or mental enhancement 泰科根公司 2023-05-05 CN disclosed